Small Molecules
28 August 2015
U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes27 August 2015
Portage’s Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-022325 August 2015
Corium Initiates Phase 1 Clinical Trial of Corplex(TM) Donepezil Transdermal System for the Treatment of Alzheimer’s Diseas25 August 2015
Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 41625 August 2015
Highland Therapeutics Announces Initiation of Second Pivotal Trial of HLD-200 in Pediatric ADHD Patients20 August 2015
Biota Advances RSV Program With Commencement of Dosing in Phase 1 Trial for Direct-Acting Antiviral BTA58520 August 2015
Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events19 August 2015
EpicentRx Announces Publication of Phase 1 Trial Results for the Anti-Cancer Agent, RRx-001, in Lancet Oncology19 August 2015
Edge Therapeutics Reports Positive Top-Line Phase 1/2 NEWTON Trial Results of EG-1962 in Aneurysmal Subarachnoid HemorrhageNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports